What is the extent of gender bias in bioinformatics?

Similar documents
Allied Health: Sustainable Integrated Health Care for all Australians

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK

BioPlex 2200 Infectious Disease Panels

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

- Network for Excellence in Health Innovation

Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance

Global EHS Resource Center

Immunohematology. IH-QC Modular System. Select. Combine. Control.

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

Access to treatment and disease burden

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Louisville '19 Attachment #69

World Connections Committee (WCC) Report

ERNDIM QAP for qualitative urinary organic acid analysis. Annual Report 2003 (Sheffield)

ETB Data. there was. compared

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

EPIDEMIOLOGY. Accurate, in-depth information for understanding and assessing targeted markets

Health Care Providers:

3.1 PHASE 2 OF THE GLOBAL PROJECT

Injection Techniques Questionnaire (ITQ) WorldWide Results Needle Gauge

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

2017 ICF GLOBAL CONSUMER AWARENESS STUDY

BACKGROUND AND RATIONALE

Bio-Rad Laboratories. Hemoglobin Testing. VARIANT II Hemoglobin Testing System For HbA 1c

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Smokefree Policies in Europe: Are we there yet?

Terms and Conditions. VISA Global Customer Assistance Services

Main developments in past 24 hours

Cardiac Assessment Controls

WCPT COUNTRY PROFILE December 2017 HUNGARY

Appendix F: Test-Curriculum Matching Analysis

EUROPEAN AEROSOL PRODUCTION

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

NobelDesign 1.3 Installation guide

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479

Tobacco control measures in the Dutch National Prevention Agreement and expected tobacco industry responses

Injection Techniques Questionnaire (ITQ) WorldWide Results Insulin Usage

TGX and TGX Stain-Free FastCast Acrylamide Kits

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

Type 1 Diabetes Australian Research Impact Analysis

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

Differences make a Difference

Kenneth W. Mahaffey, MD and Keith AA Fox, MB ChB

CND UNGASS FOLLOW UP

NobelProcera Implant Bar Overdenture EXPERIENCE THE NEW WORLD OF CAD/CAM DENTISTRY

Ethics education: global, inspiring and challenging

WCPT COUNTRY PROFILE December 2017 SWEDEN

Emily J. Hadgkiss, 1 George A. Jelinek, 1,2 Tracey J. Weiland, 1,3 Naresh G. Pereira, 4 Claudia H. Marck, 1 and Dania M.

NobelProcera Implant Bar Overdenture complete range of fixed and removable solutions.

2017 GLOBAL PAIN INDEX (GPI) Better for Everyone

Summary of Results for Laypersons

WCPT COUNTRY PROFILE December 2017 SERBIA

Case study examining the impact of German reunification on life expectancy

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

of the Bone and Joint Decade The Global Challenge of Fragility Fractures and the Role of Fragility fracture Network

FOOD TESTING RAPID'L.Mono Chromogenic Media. Detect Listeria Species in 24 Hours

Chemical compatibility of the Pall QPoint TM Docking Station - Tap Assembly with common surface disinfectants

Population- based cancer survival estimates

Country Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11

Department of Paediatric Chemical Pathology and Neonatal Screening The Children s Hospital Sheffield S10 2TH UK. Annual Report 2002.

IARC A UNIQUE AGENCY. Cancer research for cancer prevention

Cardiac Assessment Controls A critical element of reliable cardiac testing

25 September 2012 Early Years Pathfinder. misuse. Insert name of presentation on Master Slide. Presenter: Dr Sarah J Jones

For personal use only

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers NZ & Australia

The next best thing to fruits and vegetables

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

European Experience and Perspective on Assessing Value for Oncology Products. Michael Drummond Centre for Health Economics, University of York

What was the study about?

ESPEN Congress Geneva 2014 FOOD: THE FACTOR RESHAPING THE SIZE OF THE PLANET

The Official Journal of the Kettil Bruun Society for Social and Epidemiological Research on Alcohol

Third Party Controls for Your Dade Behring Systems

The health economic landscape of cancer in Europe

Modelling diabetes Professor Alastair Gray Health Economics Research Centre University of Oxford

Data Retrieval Committee Annual Report - Year 2004

The Problem Statement: 16 Sept 2008 Düsseldorf. ISBT Working Party for Rare Donors : 24 years of International Collaboration.

HRM Series PCB Power Relays

Table 15.1 Summary information for kidney cancer in Ireland, Ireland RoI NI female male female male female male % of all new cancer cases

Annual Report of the AETA Statistics Committee For Calendar Year 2006

P6KE Series DO-15. Mechanical Data

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

o Dental Implants Market By Material, Type, Structure Global Forecast To 2022 Report ID: MRDH Publishing Date: July, 2017

Transcription:

What is the extent of gender bias in bioinformatics? Keith R. Bradnam krbradnam@ucdavis.edu, @kbradnam Genome Center, University of California, Davis Introduction As a male bioinformatician, I was curious as to the extent of gender bias in my own field. I therefore designed a short online survey to examine this issue. The survey was conducted between 5 11 May 2014, and was promoted via my ACGT blog and by twitter. The objectives of this survey were to: 1. Determine whether there is a notable gender bias within the bioinformatics community 2. Investigate whether the gender bias if present manifests itself at particular stages of a career Caveats 1. The survey was connected anonymously via an online Google form. It was therefore not possible to ascertain the veracity of the answers. 2. People were asked to complete the form only if they identified their current position as being related to bioinformatics. This loose definition may have been interpreted differently by different people. 3. No comparable data was collected from a control group of people working in non-bioinformatics science careers. Therefore it is not possible to distinguish whether any gender bias found in this survey is specific to the bioinformatics community, or is present in other scientific disciplines.

The Questions Note that only questions 1,3, and 4 required responses in order to complete the survey. The survey was kept deliberately short to encourage participation. 1. Your gender Male Female Other 2. If you selected Other gender, please list which gender you identify with 3. Is your current role in academia or industry? Academia Industry Governmental Mixed predominantly industry Mixed predominantly academia Mixed predominantly governmental Mixed approximately equal between all sectors

4. Which of the following best describes your current level of career advancement? 1. Currently pursuing undergraduate degree (with focus on bioinformatics/genomics) 2. Undergraduate level position in academia or industry (e.g. Research officer / Junior specialist) 3. Currently pursuing postgraduate qualification (with focus on bioinformatics/genomics) 4. Postgraduate level position (e.g. Research assistant). MSc or PhD required for role. 5. Postdoctoral scholar / Fellow / Research Associate 6. Lecturer / Instructor/ Senior Fellow / Project Scientist (3+ years post-phd research experience) 7. Assistant Professor / Reader / Senior Lecturer (5+ years post-phd research experience) 8. Associate or Full Professor / Team Leader (7+ years post-phd research experience) 9. Senior Professorial role (e.g. head of a department, 10+ years post-phd research experience) 10. Super Senior role (e.g. Dean of a school or CEO, 15+ years post-phd research experience) Optional questions 5. Where are you based? 6. To what extent do you feel that your gender has limited your opportunities for career advancement in bioinformatics? Answers to question 5 were corrected and standardized as appropriate (e.g. England -> United Kingdom, NZ -> New Zealand). The unedited answers are included in the separate data file of all survey answers.

Results Background to survey participants As of 12th May 2014, there were 370 responses to the survey, with similar numbers of male and female survey participants (Table 1). See Discussion for how representative these numbers might be of the bioinformatics community as a whole. Table 1: Gender of survey participants. One individual identified themselves as Trans man. Gender N % Male 198 54% Female 171 46% Other 1 0% Approximately two-thirds of survey participants were located in the USA or UK, though 33 different countries were represented overall (Table 2), and the vast majority (80%) of survey participants work in the academic sector (Table 3).

Table 2: Location of survey participants. Note: this question was optional, but was answered by 351 (95%) of the survey participants. The Other category refers to one answer that was given as UK, Austria, Germany. Country N % United States of America 154 41.6% United Kingdom 90 24.3% Australia 27 7.3% Canada 12 3.2% Germany 11 3.0% Norway 5 1.4% Spain 5 1.4% Republic of Ireland 4 1.1% Austria 3 0.8% Belgium 3 0.8% Brazil 3 0.8% Denmark 3 0.8% France 3 0.8% Sweden 3 0.8% Switzerland 3 0.8% Finland 2 0.5% India 2 0.5% Netherlands 2 0.5% Chile 1 0.3% China 1 0.3% Czech Republic 1 0.3% Israel 1 0.3% Kuwait 1 0.3% Mexico 1 0.3% New Zealand 1 0.3% Other 1 0.3% Pakistan 1 0.3% Poland 1 0.3%

Portugal 1 0.3% Russia 1 0.3% Singapore 1 0.3% South Africa 1 0.3% Thailand 1 0.3% Turkey 1 0.3% Table 3: Career sector of survey participants. This survey did not originally include options to select governmental positions. It was modified very shortly after the survey was first published to allow these additional choices. Sector N % Academia 296 80% Industry 23 6% Governmental 20 5% Mixed predominantly industry 9 2% Mixed predominantly academia 19 5% Mixed predominantly governmental 0 0% Mixed approximately equal between all sectors 3 1%

Differences in career positions with respect to gender Survey participants reported their current career position; ten possible options were available, ranging from the most junior (currently pursuing undergraduate degree) to the most senior (Dean of a school or CEO). Overall, survey participants represent all stages of a bioinformatics career, with postdoctoral scholar positions (or equivalent), being the most frequent (Table 4). Table 4: Current career position of survey participants Career position N % 1. Currently pursuing undergraduate degree (with focus on bioinformatics/genomics) 12 3% 2. Undergraduate level position in academia or industry,(e.g. Research officer / Junior specialist) 18 5% 3. Currently pursuing postgraduate qualification (with focus on bioinformatics/genomics) 83 22% 4. Postgraduate level position (e.g. Research assistant). MSc or PhD required for role 45 12% 5. Postdoctoral scholar / Fellow / Research Associate 89 24% 6. Lecturer / Instructor/ Senior Fellow / Project Scientist (3+ years post-phd research experience) 43 12% 7. Assistant Professor / Reader / Senior Lecturer (5+ years post-phd research experience) 33 9% 8. Associate or Full Professor / Team Leader (7+ years post- PhD research experience) 28 8% 9. Senior Professorial role (e.g. head of a department, 10+ years post-phd research experience) 14 4% 10. Super Senior role (e.g. Dean of a school or CEO, 15+ years post-phd research experience) 5 1%

I next decided to look at the variation of these roles with respect to gender (Figure 1). As the descriptions of these ten options may be regarded subjectively, and as there are many subtle differences in position titles between academic institutions in different countries I decided to pool results together from adjacent categories. I.e. the first data point in Figure 1 represents anyone who answered 1 or 2 to this question, the second data point represents anyone who answered 2 or 3 etc. Figure 1: Percentage of male/female survey participants at different career stages. X-axis reflects pooling of data from adjacent career stage categories, see Table 4 for details. This suggests that there is no notable gender bias in early bioinformatics career positions but that bias appears at later career stage (e.g. Associate or Full Professor / Team Leader role). The last data point in Figure 1 suggests a narrowing in gender bias at the highest career stages. However, this also represents the category with the fewest survey participants (10 men and 9 women), so this may simply reflect sampling artifacts.

Effect of gender on limiting opportunities for career advancement Participants were asked whether they felt their gender had limited their opportunities for career advancement in bioinformatics; five possible responses were allowed (ranging from no limitations to substantial limitations). The majority of respondents (61%) listed that they had experienced no limitations (Table 5). Table 5: Limitations on opportunities for career advancement due to gender. Note: this question was optional, but was answered by 356 (96%) of the survey participants. Limitations on career N % No limitations 217 61% Some limitations 96 27% Moderate limitations 31 9% Major limitations 11 3% Substantial limitations 2 1% However, when results are split by gender there are considerable differences in how males and females answered this question (Figure 2). Of the 195 male participants who answered this question, 80% expressed an opinion that there had been no limitation to their opportunities for career advancement due to their gender. In contrast, only 34% of female respondents (58 out of 171) expressed the same opinion.

Figure 2: Percentage of male/female survey participants that have experienced limitations for career advancement due to gender. X-axis reflects pooling of data from adjacent categories listed in Table 5. As the majority of limitations on career opportunities are experienced by women, I investigated whether this is something that happens at all career stages or not. Even in the earliest two career stages, almost half of all female respondents had experienced some form of career limitation due to their gender (Figure 3). By later career stages, the majority of female survey participants have experienced some form of limitation to their career opportunities.

Figure 3: Percentage of female participants that expressed any form of limitation of career opportunities due to gender at different career stages. Experience of career limitations is defined as answering in the last four categories of Table 5 (some limitations to severe limitations). Gender differences with respect to geographic location By combining answers from different survey questions, I investigated whether the experiences of career limitations due to gender varies with location. I calculated the percentage of survey participants that had experienced any form of career limitation due to gender (Figure 4). Suitable numbers of survey responses (>10) were available for the USA, UK, Australia, and Canada; but an Other Western Europe category was also made by pooling data from Austria, Belgium, Denmark, Finland, France, Germany, Netherlands, Norway, Portugal, Republic of Ireland, Spain, Sweden, and Switzerland. The limitations on career advancement opportunities was determined by summing responses in categories 2 5 from Table 5 (some limitations to substantial limitations).

Figure 4: Percentage of male/female survey participants that have experienced limitations for career advancement due to gender. Results separated by geographic location (x-axis). Size of datasets for each region (M+F): USA 70+81, UK 46+43, Western Europe 32+15, Australia 18+9, Canada 6+6. For all regions, there is a notable trend towards women reporting more limitations to their opportunities for career advancement than men. Australian survey participants recorded the greatest gender difference, with 8 out of 9 females reporting some level of career limitation, but only 2 out of 18 males. When comparing the two countries with the greatest number of survey participants (UK and USA), females in the USA were more likely to report some form of career limitation due to gender than compared to females in the UK (69% vs 58%).

Discussion A survey that is trying to find out the extent of gender bias may itself be biased to attracting responses from people for which this is an important issue. Furthermore, as this survey was heavily promoted through use of twitter, it might also reflect biases in the gender ratio of twitter users. A 2013 report by the Pew Research Center showed comparable numbers of men and women using twitter, though other data suggests that females account for a much higher fraction of twitter users. The responses to this survey may not be representative of the bioinformatics community as a whole. Twitter provides some analytics data for some accounts which tries to identify the likely gender of users that follow those accounts (see analytics.twitter.com). The gender ratio of followers to twitter accounts that are largely identified as being bioinformatics-related may therefore reveal something about the background gender ratio in the bioinformatics community. The @Assemblathon account has 1,882 followers and twitter identifies 81% of the followers as being male. Likewise, the @GenomeWeb account has 4,398 followers with 74% being identified as male. Both of these accounts can be identified as being gender neutral as they are not obviously associated with any one individual. Therefore, it is possible that this survey has attracted a higher proportion of responses from women than might be expected based on the overall make up of the bioinformatics community on twitter. Overall, this survey finds that female bioinformaticians are notably underrepresented at later career stages, and that they experience more limitations on their opportunities for career advancement compared to their male colleagues. Unfortunately, it was outside the scope of this survey to investigate how these results compare to scientists in other fields. Therefore it remains unclear whether this gender bias in bioinformatics is better or worse than in comparable fields.

Even though this report has focused on the disparities affecting female bioinformaticians, it should still be noted that 20% of all male bioinformaticians reported that they felt their gender had limited their opportunities for career advancement. One particular cause for concern is that even though there is equality in the numbers of male and female bioinformaticians in early career stages, many of those females expressed that their career opportunities have already been limited because of their gender (Figure 3). This suggests that it is not sufficient to assume that equal numbers of male/female bioinformaticians represents a situation that is free from gender bias.

Written in Markdown format on a 13" Apple MacBook Air, using nvalt and converted to PDF using Marked.